Article info

PDF

Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study

Authors

  1. Correspondence to Professor Toshinari Takamura; ttakamura{at}m-kanazawa.jp
View Full Text

Citation

Shima KR, Ota T, Kato K, et al
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study

Publication history

  • Received August 31, 2017
  • Revised February 13, 2018
  • Accepted February 20, 2018
  • First published March 17, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.